SK-216

CAS : 654080-03-2

Ref. 3D-EBB08003

Informations sur le produit

• Nom: SK-216

Description

SK-216 is a drug that inhibits the synthesis of messenger RNA and suppresses angiogenesis. This drug has been shown to reduce the number of blood vessels in lung fibroblasts and subcutaneous tumors in mice, as well as inhibit the proliferation of cancer cells. SK-216 also stimulates lipoprotein lipase activity in wild-type mice and blocks angiogenesis by inhibiting the production of angiogenic factors such as VEGF and TGF-β1. SK-216 is currently being studied for its potential use in the treatment of pleural mesothelioma, urokinase-type plasminogen activator (uPA) receptor positive epithelial mesenchymal cells.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 533.5 g/mol
• Formule: C₂₉H₂₉NNa₂O₆
• Degré de pureté: Min. 95%